Page last updated: 2024-09-04

carbapenems and Pneumonia, Bacterial

carbapenems has been researched along with Pneumonia, Bacterial in 101 studies

Research

Studies (101)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (3.96)	18.2507
2000's	27 (26.73)	29.6817
2010's	53 (52.48)	24.3611
2020's	17 (16.83)	2.80

Authors

Authors	Studies
Li, M; Li, S; Xu, L; Yang, P	1
Bou, G; Díaz-Regañón, J; Fariñas, MC; Fenoll, R; Ferrer, R; Gómez-Ulloa, D; Lara, N; López, D; Lozano, V; Maseda, E; McCann, E; Salavert, M	1
Nathanson, BH; Puzniak, LA; Shorr, AF; Zilberberg, MD	1
Chan, MC; Chen, CM; Chen, WC; Chou, YC; Feng, JY; Peng, CK; Sheu, CC; Wang, SH; Wu, BR; Yang, KY; Zheng, ZR	1
Lodise, TP; O'Donnell, JN	1
Himmel, LE; Kunkle, DE; Maloney, KN; Monteith, AJ; Sheldon, JR; Skaar, EP	1
Aanensen, DM; Beis, K; Brett, SJ; Clements, A; David, S; Frankel, G; Giani, T; Low, WW; Morecchiato, F; Rossolini, GM; Rouskin, S; Sanchez-Garrido, J; Wong, JLC; Woo, JZ	1
Dillon, RJ; Nathanson, BH; Puzniak, LA; Shorr, AF; Zilberberg, MD	1
Bassetti, M; Bini, L; Giacobbe, DR; Magnè, F; Vena, A	1
Aiqin, L; Wenwen, S; Xiquan, L	1
Bai, XR; Fan, L; Li, WC; Lou, R; Qu, X; Wang, YG; Wang, ZZ; Wu, YC; Yan, SY; Zhang, L; Zhang, W	1
Bernardo, M; Bitterman, R; Carmeli, Y; Daikos, G; Daitch, V; Dishon-Benattar, Y; Durante-Mangoni, E; Friberg, LE; Iossa, D; Leibovici, L; Lellouche, J; Mouton, JW; Nutman, A; Paul, M; Skiada, A; Temkin, E; Theuretzbacher, U; Yahav, D; Zusman, O	1
Cen, H; Zhang, L	1
Ariyasu, M; Bassetti, M; Doi, Y; Echols, R; Ferrer, R; Lodise, TP; Matsunaga, Y; Naas, T; Nagata, TD; Niki, Y; Paterson, DL; Portsmouth, S; Torre-Cisneros, J; Toyoizumi, K; Wunderink, RG	1
Chan, MC; Chen, CM; Feng, JY; Lin, YC; Lin, YT; Peng, CK; Shen, YC; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR	1
Brito, JCM; Cardoso, VN; de Assis, DCS; de Lima, ME; de Paiva, MC; Fernandes, SOA; Lima, WG; Pizarro, ACST; Vianna, MAMM	1
Peters, AT; Pickens, CI; Postelnick, MJ; Qi, C; Wunderink, RG; Zembower, TR	1
Bonten, MJ; Bravo-Ferrer, J; Cuperus, N; Daikos, G; de Kraker, M; Feifel, J; Folgori, L; Goossens, H; Gutiérrez-Gutiérrez, B; Kostyanev, T; O'Brien, S; Pascual, A; Raka, L; Rodríguez-Baño, J; Sojo-Dorado, J	1
Huang, L; Qin, RR; Sun, LY; Wang, Z	1
Cienfuegos-Gallet, AV; Higuita-Gutiérrez, LF; Jiménez Quiceno, JN; López-López, L; Vargas-Alzate, CA	1
Abdollahi, A; Beigmohammadi, MT; Doomanlou, M; Khalili, H; Mohammadi, M; Shojaei, L	1
Cho, EB; Choi, SH; Chung, JW; Lee, MK	1
Daikos, GL; Miriagou, V; Piperaki, ET; Tzouvelekis, LS	1
Jeon, J; Park, JH; Yong, D	1
Chen, S; Deng, K; Du, X; Feng, G; Shen, Z; Xu, X; Yang, L; Yao, J	1
Allou, N; Allyn, J; Aujoulat, T; Ferdynus, C; Lair, T; Lugagne, N; Miltgen, G; Teysseyre, L	1
Chida, K; Harada, M; Inui, N; Matsuo, Y; Nakamura, Y; Suda, T; Wajima, T	1
Thamlikitkul, V; Tiengrim, S	1
Shorr, AF; Zilberberg, MD	1
Falagas, ME; Lourida, P; Poulikakos, P; Rafailidis, PI; Tansarli, GS	1
Chong, YP; Choo, EJ; Chung, JW; Jeon, MH; Kim, DM; Kim, T; Kim, YS; Lee, HK; Moon, C; Park, SY; Peck, KR	1
Fang, X; Gong, M; Xia, J; Xu, Y; Zhang, D; Zhou, Y	1
Gastmeier, P; Hummel, M; Klefisch, FR; Kola, A; Schweizer, C; Zweigner, J	1
Li, J; Mukhopadhyay, A; Tambyah, PA; Vasudevan, A; Yuen, EG	1
Ghebremedhin, B; Rasche, K; Yayan, J	1
Cheng, CW; Hsu, PC; Huang, CT; Lee, MH; Leu, HS; Lin, HS; Ye, JJ	1
Ikawa, K; Ishihara, N; Isobe, T; Karino, F; Miura, K; Morikawa, N; Naora, K; Nishimura, N; Tamaki, H	1
Azouri, T; Bathina, P; Kandipalli, D; Kaplansky, T; Kaye, KS; Lazarovitch, T; Marchaim, D; Maskit, M; Ofer-Friedman, H; Sharma, S; Shefler, C; Tal-Jasper, R; Tirosh, A; Zaidenstein, R	1
Hirose, Y; Ishikawa, H; Kamata, K; Kanemoto, K; Shiotani, S; Suzuki, H; Suzuki, M; Tokuda, Y	1
Nieberg, P; Ny, P; Wong-Beringer, A	1
Barauskas, V; Bradley, JS; Cannavino, CR; Castaneda-Ruiz, B; Cirillo, I; Emeryk, A; Go, O; Redman, R; Senatorova, G	1
Jaworowska, J; Jurczak, A; Majewski, P; Ojdana, D; Olszańska, D; Sacha, P; Sieńko, A; Tryniszewska, E; Wieczorek, P	1
Cprek, JB; Gallagher, JC	1
Akata, K; Ishimoto, H; Kawanami, T; Kido, T; Mukae, H; Naito, K; Nishida, C; Noguchi, S; Sakamoto, N; Yamasaki, K; Yatera, K	1
Huang, CT; Huang, PY; Lee, MH; Lin, HS; Wu, YM; Yang, CC; Ye, JJ; Yeh, CF	1
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N	1
Friedland, I; Kaniga, K; Ketter, N; Lee, M; Lobo, SM; Niederman, M; Prokocimer, P; Réa-Neto, A; Schroeder, E	1
Cheong, HJ; Kim, WJ; Lee, J; Song, JY; Sung, AK	1
Izumikawa, K; Kakeya, H; Kohno, S; Mihara, T; Nakamura, S; Seki, M; Soejima, Y; Tashiro, T; Yamamoto, Y; Yanagihara, K	1
Micek, ST; Neuner, EA; Ritchie, DJ	1
Ishikawa, T; Ishitsuka, K; Katsuya, H; Sasaki, H; Takamatsu, Y; Takata, T; Tamura, K	1
Biek, D; Janes, R; Morrissey, I	1
Catherinot, E; El Karoui, K; Ferroni, A; Guillet, C; Hiesse, C; Hue, K; Lanternier, F; Lecuit, M; Lortholary, O; Mainardi, JL; Mamzer Bruneel, MF; Méchaï, F; Sekkal, N; Viard, JP	1
Alhajhusain, A; El Solh, AA	1
Depestel, DD; Paterson, DL	1
Chen, CC; Chen, CH; Chiang, SR; Chou, CH; Chuang, YC; Ko, WC; Lee, NY; Tang, HJ	1
Guery, BP	1
Catherinot, E; Degand, N; Lanternier, F; Lebeaux, D; Lecuit, M; Lortholary, O; Mainardi, JL; Podglajen, I; Rubio, MT; Suarez, F	1
Ikeda, H; Kuroki, H; Saito, N; Tateno, N	1
Lin, R; Nandy, P; Samtani, MN	1
Kimouli, M; Kosmopoulou, O; Petropoulou, D; Poulou, A; Pournaras, S; Ranellou, K; Tsakris, A; Voulgari, E	1
Fujita, M; Ishikura, H; Kitamura, T; Matsumoto, T; Toyoshima, H; Watanabe, K; Yoshimura, C	1
Elborn, JS; Parkins, MD	1
De Waele, JJ; Deja, M; Diaz, E; Guven, M; Koulenti, D; Lisboa, T; Mañez, R; Martin-Loeches, I; Putensen, C; Rello, J; Ulldemolins, M	1
Boutoille, D; Bretonnière, C; Caillon, J; Guitton, C; Jacqueline, C; Le Mabecque, V; Miégeville, AF; Potel, G; Villers, D	1
Apisarnthanarak, A; Mundy, LM	1
alNaiemi, N; Bernards, A; Kalpoe, J; Lettinga, K; Paltansing, S; van Apeldoorn, M	1
Abbanat, D; Barron, A; Bunting, RA; Fernandez, J; Flamm, RK; Hall, L; Hilliard, JJ; Lynch, AS; Melton, JL; Ward, CK	1
Cheong, HJ; Choi, WS; Heo, JY; Kim, WJ; Noh, JY; Song, JY	1
Al Naiemi, N; Kalpoe, JS; Nordmann, P; Poirel, L	1
Fujisawa, S; Goto, H; Ishigatsubo, Y; Ito, M; Kanamori, H; Kaneko, T; Miyazawa, N; Morita, S; Ono, S; Watanuki, Y; Yamaguchi, N	1
Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN	1
Avazashvili, N; Chikviladze, D; Gachechiladze, Kh; Metreveli, D; Mikeladze, M; Nozadze, T	1
Sakata, H	1
Dong, L; Li, HY; Wang, ZY; Zhang, TQ	1
Chen, CC; Chen, CH; Chiang, SR; Chuang, YC; Ko, WC; Lee, NY; Shieh, JM; Tang, HJ	1
Bishara, J; Cohen, J; Goldberg, E; Lev, S; Singer, P	1
Boutoille, D; Bretonnière, C; Caillon, J; Desessard, C; Guitton, C; Jacqueline, C; Le Mabecque, V; Miégeville, AF; Potel, G; Villers, D	1
Caprioli, RM; Chazin, WJ; Hood, MI; Kehl-Fie, TE; Moore, JL; Mortensen, BL; Skaar, EP; Sugitani, N; Zhang, Y	1
Lipman, J; Roberts, JA	1
van der Meer, YG; van Zanten, AR	1
Cravarezza, P; Donati, P; Franchino, L; Grassi, V; Pozzi, A; Prometti, P; Ravizzola, G; Romanelli, G; Zulli, R	1
Orlov, VA; Shenderovich, VA; Smirnova, LB; Sokolova, VI	1
Ariza, J; Ayats, J; Borraz, C; Cabellos, C; Corbella, X; Doménech, A; Gudiol, F; Montero, A; Tubau, F	1
Asaoka, N; Fujita, K; Honda, Y; Kurihara, T; Ohba, H; Okimoto, N; Osaki, K; Yamato, K	1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W	1
Kollef, MH	1
Bernabéu-Wittel, M; de Cueto, M; del Carmen Conejo, M; García, I; Jiménez-Mejías, ME; Martínez-Martínez, L; Pachón, J; Pachón-Ibáñez, ME; Pascual, A; Pichardo, C	1
Koulenti, D; Rello, J	1
Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK	1
Aisenberg, G; Dickey, BF; Kontoyiannis, DP; Raad, II; Rolston, KV; Safdar, A	1
Falagas, ME; Manta, KG; Siempos, II; Vardakas, KZ	1
Furukawa, K	1
Joseph, J; Rodvold, KA	1
Bando, T; Chiba, S; Hiraga, Y; Hirai, Y; Inoue, H; Ito, T; Kikuchi, K; Kobayashi, H; Matsumoto, H; Moriya, K; Mouri, T; Nakashima, M; Ohmichi, M; Ohsaki, Y; Saito, A; Sakamoto, M; Sasaki, N; Shirato, K; Suda, T; Takeuchi, K; Tanifuji, Y; Tanno, Y; Tsuzino, M; Yoshida, M	1
Katsu, K; Nakamura-Kamijo, M; Ohba, F; Watanabe, N	1
Garau, J; Martínez Lacasa, J	1
Nakamura, J; Soejima, R	1
Jacolot, A; Leotard, S; Louchahi, K; Mimoz, O; Nordmann, P; Padoin, C; Petitjean, O	1
Kobashi, Y; Matsushima, T; Okimoto, N	1
Bellais, S; Jacolot, A; Léotard, S; Mimoz, O; Nordmann, P; Petitjean, O	1

Reviews

18 review(s) available for carbapenems and Pneumonia, Bacterial

Article	Year
New Perspectives on Antimicrobial Agents: Imipenem-Relebactam. Antimicrobial agents and chemotherapy, 2022, 07-19, Volume: 66, Issue:7 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa	2022
New antibiotics for Gram-negative pneumonia. European respiratory review : an official journal of the European Respiratory Society, 2022, Dec-31, Volume: 31, Issue:166 Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Pneumonia, Bacterial	2022
Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019, Volume: 25, Issue:8 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Observational Studies as Topic; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome	2019
Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis. American journal of infection control, 2019, Volume: 47, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Clinical Decision Rules; Female; Humans; Male; Pneumonia, Bacterial; Risk Factors	2019
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Critical Illness; Drug Therapy, Combination; Enterobacteriaceae; Humans; Minocycline; Pneumonia, Bacterial; Survival Analysis; Tigecycline; Urinary Tract Infections	2014
New antibiotics for healthcare-associated pneumonia. Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin	2009
Update on the treatment of Pseudomonas aeruginosa pneumonia. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:2 Topics: Anti-Bacterial Agents; Biomedical Research; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Pneumonia, Bacterial; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections	2009
Doripenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jul-15, Volume: 49, Issue:2 Topics: Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Peritonitis; Pneumonia, Bacterial; Seizures; Urinary Tract Infections	2009
[Doripenem: need for a new carbapenem]. Medecine et maladies infectieuses, 2009, Volume: 39, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Carbapenems; Clinical Trials as Topic; Cross Infection; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Humans; Nervous System Diseases; Peritonitis; Pneumonia, Bacterial; Pseudomonas aeruginosa; Urinary Tract Infections	2009
Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:9 Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cystic Fibrosis; Doripenem; Humans; Minocycline; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Stenotrophomonas maltophilia; Tigecycline	2010
Appropriate use of the carbapenems. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections	2004
Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems. Respiratory care, 2004, Volume: 49, Issue:12 Topics: Algorithms; Anti-Bacterial Agents; Carbapenems; Clinical Trials as Topic; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Pneumonia, Bacterial; Practice Guidelines as Topic; Risk Factors; Severity of Illness Index	2004
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:12 Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin	2006
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia. The European respiratory journal, 2007, Volume: 29, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aminoglycosides; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Humans; Immunocompetence; Intensive Care Units; Meropenem; Pneumonia, Bacterial; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiration, Artificial; Survival Rate; Thienamycins; Treatment Outcome	2007
[Importance of appropriate carbapenem use to reduce carbapenem--resistant Pseudomonas aeruginosa]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1 Topics: Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Utilization; Humans; Japan; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors	2007
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome	2008
[The role of carbapenems in the treatment of nosocomial infection]. Enfermedades infecciosas y microbiologia clinica, 1997, Volume: 15 Suppl 1 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Pneumonia, Bacterial; Skin Diseases, Infectious; Thienamycins	1997
[Serratia marcescens pneumonia]. Ryoikibetsu shokogun shirizu, 1999, Issue:23 Pt 1 Topics: Carbapenems; Diagnosis, Differential; Humans; Immunocompromised Host; Pneumonia, Bacterial; Prognosis; Serratia Infections; Serratia marcescens	1999

Trials

10 trial(s) available for carbapenems and Pneumonia, Bacterial

Article	Year
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:9 Topics: Aged; Aged, 80 and over; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	2020
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. The Lancet. Infectious diseases, 2021, Volume: 21, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sepsis; Urinary Tract Infections; Young Adult	2021
Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia. Journal of comparative effectiveness research, 2018, Volume: 7, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam	2018
Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia. The Pediatric infectious disease journal, 2015, Volume: 34, Issue:11 Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Doripenem; Hospitalization; Humans; Infant; Intraabdominal Infections; Pneumonia, Bacterial; Treatment Outcome; Urinary Tract Infections	2015
Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study. Current medical research and opinion, 2008, Volume: 24, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Carbapenems; Cross Infection; Doripenem; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Prospective Studies; Tazobactam; Treatment Outcome	2008
Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Pyelonephritis; Renal Insufficiency; Urinary Tract Infections; Young Adult	2010
Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility. Critical care medicine, 2013, Volume: 41, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Middle Aged; Monte Carlo Method; Obesity; Pneumonia, Bacterial	2013
Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Community-Acquired Infections; Costs and Cost Analysis; Drug Combinations; Drug Costs; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipenem; Male; Meropenem; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome	2002
[Study of administration times and clinical efficacy of carbapenems in the treatment of moderate community-acquired bacterial pneumonia]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2004, Volume: 42, Issue:10 Topics: Adult; Aged; Carbapenems; Community-Acquired Infections; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies	2004
[A comparative study on the efficacies of ritipenem acoxil and cefotiam hexetil in bacterial pneumonia by the double-blind method]. The Japanese journal of antibiotics, 1996, Volume: 49, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Carbapenems; Cefotiam; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prodrugs	1996

Other Studies

73 other study(ies) available for carbapenems and Pneumonia, Bacterial

Article	Year
Blocking of Birc3/TLR4/Myd88 signaling protects carbapenem-resistant klebsiella pneumoniae in a mouse model of infection. Transplant immunology, 2021, Volume: 69 Topics: Animals; Anti-Bacterial Agents; Baculoviral IAP Repeat-Containing 3 Protein; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Mice; Myeloid Differentiation Factor 88; Pneumonia, Bacterial; Signal Transduction; Toll-Like Receptor 4	2021
Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2021, Volume: 34, Issue:6 Topics: Aftercare; Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Patient Discharge; Pneumonia, Bacterial; Retrospective Studies; Spain; Urinary Tract Infections; Ventilators, Mechanical	2021
Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019. Infection control and hospital epidemiology, 2022, Volume: 43, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; Escherichia coli; Healthcare-Associated Pneumonia; Hospitals; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Retrospective Studies; Staphylococcus aureus; United States; Ventilators, Mechanical	2022
The necessity of a loading dose when prescribing intravenous colistin in critically ill patients with CRGNB-associated pneumonia: a multi-center observational study. Critical care (London, England), 2022, 04-04, Volume: 26, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Gram-Negative Bacteria; Humans; Pneumonia, Bacterial; Retrospective Studies	2022
Lipocalin-2 is an essential component of the innate immune response to Acinetobacter baumannii infection. PLoS pathogens, 2022, Volume: 18, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacteremia; Carbapenems; COVID-19; Humans; Immunity, Innate; Iron; Lipocalin-2; Mice; Pandemics; Pneumonia, Bacterial; Siderophores	2022
Recurrent emergence of Proceedings of the National Academy of Sciences of the United States of America, 2022, 09-20, Volume: 119, Issue:38 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; Carbapenems; Disease Models, Animal; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Mutation; Phylogeny; Pneumonia, Bacterial; Porins; RNA, Messenger	2022
The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012-2019. BMC infectious diseases, 2022, Oct-05, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Hospitals; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Retrospective Studies; Ventilators, Mechanical	2022
Risk factors of carbapenem-resistant gram-negative bacteria pneumonia and mortality. Cellular and molecular biology (Noisy-le-Grand, France), 2022, Sep-30, Volume: 68, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pneumonia, Bacterial; Retrospective Studies; Risk Factors	2022
Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant Gram-negative bacterium pneumonia in intensive care units. BMC infectious diseases, 2023, Nov-27, Volume: 23, Issue:1 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Fibrinogen; Gram-Negative Bacteria; Humans; Intensive Care Units; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Tigecycline; Treatment Outcome	2023
Management of carbapenem-resistant Klebsiella pneumoniae infection in a patient with diabetic foot ulcer and necrotizing soft tissue infection, bacteremia and lung infection: A case report. Asian journal of surgery, 2020, Volume: 43, Issue:9 Topics: Aged; Amputation, Surgical; Bacteremia; Carbapenems; Debridement; Diabetic Foot; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Leg; Male; Necrosis; Negative-Pressure Wound Therapy; Pneumonia, Bacterial; Soft Tissue Infections	2020
Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome	2021
A short synthetic peptide, based on LyeTx I from Lycosa erythrognatha venom, shows potential to treat pneumonia caused by carbapenem-resistant Acinetobacter baumannii without detectable resistance. The Journal of antibiotics, 2021, Volume: 74, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Carbapenems; Chlorocebus aethiops; Drug Resistance, Bacterial; Drug Stability; Drug Synergism; Female; Humans; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Pneumonia, Bacterial; Spider Venoms; Vero Cells	2021
Decreasing incidence of Infection control and hospital epidemiology, 2022, Volume: 43, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Incidence; Pneumonia, Bacterial; Quinolones; Retrospective Studies; Vancomycin	2022
EUropean prospective cohort study on BMJ open, 2017, 04-03, Volume: 7, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cause of Death; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Hospitalization; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Mortality; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome; Urinary Tract Infections	2017
Risk Factors for Carbapenem-resistant Chinese medical journal, 2018, Jan-05, Volume: 131, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Logistic Models; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Risk Factors	2018
High excess costs of infections caused by carbapenem-resistant Gram-negative bacilli in an endemic region. International journal of antimicrobial agents, 2018, Volume: 51, Issue:4 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colombia; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Female; Gram-Negative Bacterial Infections; Health Care Costs; Humans; Intraabdominal Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Surgical Wound Infection	2018
Changes in the early mortality of adult patients with carbapenem-resistant Acinetobacter baumannii bacteremia during 11 years at an academic medical center. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:1 Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Catheter-Related Infections; Cross Infection; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Risk Factors	2019
Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia. BMC microbiology, 2019, 04-02, Volume: 19, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Bacteriophages; Carbapenems; Disease Models, Animal; Drug Resistance, Bacterial; Female; Larva; Mice; Mice, Inbred C57BL; Moths; Phage Therapy; Pneumonia, Bacterial; Republic of Korea	2019
Derivation and validation of a simple score to predict the presence of bacteria requiring carbapenem treatment in ICU-acquired bloodstream infection and pneumonia: CarbaSCORE. Antimicrobial resistance and infection control, 2019, Volume: 8 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; France; Hospitals, University; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Predictive Value of Tests; Prospective Studies; Retrospective Studies; Severity of Illness Index; Young Adult	2019
Pharmacokinetic analysis of doripenem in elderly patients with nosocomial pneumonia. International journal of antimicrobial agents, 2013, Volume: 42, Issue:2 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Chromatography, Liquid; Cross Infection; Doripenem; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Plasma; Pneumonia, Bacterial; Tandem Mass Spectrometry; Time Factors	2013
In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii. International journal of antimicrobial agents, 2013, Volume: 42, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Asia, Southeastern; beta-Lactam Resistance; Carbapenems; Cross Infection; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial	2013
Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009. Journal of hospital medicine, 2013, Volume: 8, Issue:10 Topics: Adult; Aged; Carbapenems; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; United States; Young Adult	2013
Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea. Diagnostic microbiology and infectious disease, 2014, Volume: 78, Issue:4 Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Critical Illness; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Republic of Korea; Retrospective Studies; Risk Factors	2014
A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 23 Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Thienamycins	2014
A carbapenem-resistant Klebsiella pneumoniae outbreak following bronchoscopy. American journal of infection control, 2014, Volume: 42, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Bronchoscopy; Carbapenems; Disease Outbreaks; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia, Bacterial	2014
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study. BMC infectious diseases, 2014, Nov-25, Volume: 14 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Critical Illness; Cross Infection; Decision Support Techniques; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Risk Factors; Surgical Procedures, Operative; Systemic Inflammatory Response Syndrome; Urinary Tract Infections	2014
No carbapenem resistance in pneumonia caused by Klebsiella species. Medicine, 2015, Volume: 94, Issue:6 Topics: Aged; Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Male; Pneumonia, Bacterial; Retrospective Studies	2015
Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Infectious diseases (London, England), 2015, Volume: 47, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Taiwan; Time Factors	2015
Evaluation of a pharmacokineticpharmacodynamic approach using software to optimize the carbapenem antibiotic regimen. International journal of clinical pharmacology and therapeutics, 2015, Volume: 53, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Computer Simulation; Doripenem; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Drug Therapy, Computer-Assisted; Female; Humans; Kidney; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Pneumonia, Bacterial; Prospective Studies; Software; Thienamycins; Treatment Outcome	2015
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae. Infection control and hospital epidemiology, 2015, Volume: 36, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Intraabdominal Infections; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections	2015
Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Community-Acquired Infections; Cross Infection; Female; Hospital Mortality; Humans; Male; Middle Aged; Needs Assessment; Organizational Policy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Prognosis; Pseudomonas Infections	2015
Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections. American journal of infection control, 2015, Oct-01, Volume: 43, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Risk Factors; Treatment Outcome; Urinary Tract Infections; Young Adult	2015
First Report of Klebsiella pneumoniae-Carbapenemase-3-Producing Escherichia coli ST479 in Poland. BioMed research international, 2015, Volume: 2015 Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Tigecycline	2015
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections	2016
Clinical efficacy and safety of high-dose doripenem in Japanese patients with pneumonia. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Humans; Japan; Male; Pneumonia, Bacterial; Prospective Studies; Sputum; Treatment Outcome	2016
Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex. BMC infectious diseases, 2016, 08-05, Volume: 16 Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Taiwan; Tigecycline; Treatment Outcome	2016
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam. Clinical therapeutics, 2016, Volume: 38, Issue:9 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam	2016
Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. International journal of antimicrobial agents, 2009, Volume: 33, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppression Therapy; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Pneumonia, Bacterial; Rifampin; Treatment Outcome	2009
[Clinical characteristics of pneumonia in the oldest old patients]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2008, Volume: 46, Issue:9 Topics: Age Factors; Aged, 80 and over; Anorexia; Carbapenems; Cerebrovascular Disorders; Community-Acquired Infections; Dementia; Female; Humans; Length of Stay; Male; Penicillins; Pneumonia, Bacterial; Retrospective Studies; Staphylococcus aureus	2008
A patient with acute myeloid leukemia who developed fatal pneumonia caused by carbapenem-resistant Bacillus cereus. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:1 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bacillaceae Infections; Bacillus cereus; beta-Lactam Resistance; Carbapenems; Fatal Outcome; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lung; Male; Middle Aged; Neutropenia; Pneumonia, Bacterial; Remission Induction; Tomography, X-Ray Computed	2009
ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Carbapenems; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial	2009
Synergistic effect of carbapenem-teicoplanin combination during severe Rhodococcus equi pneumonia in a kidney transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:4 Topics: Actinomycetales Infections; Anti-Bacterial Agents; Carbapenems; Drug Synergism; Drug Therapy, Combination; Humans; Kidney Transplantation; Lung Abscess; Male; Middle Aged; Pneumonia, Bacterial; Rhodococcus equi; Severity of Illness Index; Teicoplanin; Treatment Outcome	2009
Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Critical care medicine, 2009, Volume: 37, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Female; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Time Factors; Trachea	2009
Nocardia pseudobrasiliensis as an emerging cause of opportunistic infection after allogeneic hematopoietic stem cell transplantation. Journal of clinical microbiology, 2010, Volume: 48, Issue:2 Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Carbapenems; Drug Resistance, Bacterial; Hematopoietic Stem Cell Transplantation; Humans; Male; Microbial Sensitivity Tests; Microscopy, Fluorescence; Middle Aged; Nocardia; Nocardia Infections; Opportunistic Infections; Pneumonia, Bacterial; Radiography, Thoracic; Tomography	2010
Investigation of pneumonia-causing pathogenic organisms in children and the usefulness of tebipenem pivoxil for their treatment. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2010, Volume: 16, Issue:4 Topics: Adolescent; Carbapenems; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Nasopharynx; Pneumonia, Bacterial; Sputum	2010
In vivo acquisition of a plasmid-mediated bla(KPC-2) gene among clonal isolates of Serratia marcescens. Journal of clinical microbiology, 2010, Volume: 48, Issue:7 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Female; Greece; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Pneumonia, Bacterial; Serratia Infections; Serratia marcescens	2010
[A case of hospital-acquired pneumonia caused by intermediately susceptible carbapenem Acinetobacter baumannii]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2010, Volume: 84, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Cross Infection; Humans; Male; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones	2010
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. The European respiratory journal, 2011, Volume: 37, Issue:6 Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Europe; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Piperacillin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones; Respiration, Artificial; Severity of Illness Index; Treatment Outcome	2011
Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:11 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Blood; Carbapenems; Disease Models, Animal; Doripenem; Female; Imipenem; Infusions, Intravenous; Lung; Meropenem; Plasma; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Spleen; Thienamycins; Treatment Outcome	2010
Use of high-dose 4-hour infusion of doripenem, in combination with fosfomycin, for treatment of carbapenem-resistant Pseudomonas aeruginosa pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Dec-01, Volume: 51, Issue:11 Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa	2010
[Fatal pneumonia caused by carbapenem resistant Klebsiella pneumoniae]. Nederlands tijdschrift voor geneeskunde, 2010, Volume: 154, Issue:45 Topics: Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial	2010
Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; Carbapenems; Cytokines; Disease Models, Animal; Doripenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Treatment Outcome	2011
Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections. Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Animals; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Models, Animal; Female; Genes, Bacterial; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Republic of Korea; Rifampin; Risk Factors	2011
Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands. Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 5 Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Fatal Outcome; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Netherlands; Pneumonia, Bacterial; Travel	2011
Clinical efficacy of carbapenems on hospital-acquired pneumonia in accordance with the Japanese Respiratory Society Guidelines for management of HAP. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Female; Guideline Adherence; Humans; Japan; Male; Middle Aged; Pneumonia, Bacterial; Practice Guidelines as Topic; Prognosis; Prospective Studies; Reproducibility of Results; Treatment Outcome	2011
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study]. Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey	2011
[Microbial spectrum of nosocomial pneumonia in traumatological patients]. Georgian medical news, 2011, Issue:194 Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Female; Hospitals; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Wounds and Injuries	2011
[Clinical efficacy of tebipenem pivoxil treatment in children with pneumonia, who had no relief despite having administered oral beta-lactam antibiotics]. The Japanese journal of antibiotics, 2011, Volume: 64, Issue:3 Topics: Administration, Oral; Amdinocillin Pivoxil; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus pneumoniae; Treatment Failure; Treatment Outcome	2011
[Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2011, Volume: 49, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Infective Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies	2011
Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Cytokines; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia, Bacterial; Stem Cells; Thienamycins	2012
Organ transplantation from a donor colonized with a multidrug-resistant organism: a case report. Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:3 Topics: Adolescent; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Lung Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Tissue and Organ Harvesting; Tissue Donors; Young Adult	2012
Evaluation of doripenem in an experimental model of resistant Pseudomonas aeruginosa pneumonia. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactam Resistance; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Humans; Imipenem; Lung; Meropenem; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Thienamycins; Treatment Outcome	2012
Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration. PLoS pathogens, 2012, Volume: 8, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Biological Transport, Active; Carbapenems; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Humans; Leukocyte L1 Antigen Complex; Lung; Manganese; Mice; Mice, Knockout; Neutrophil Infiltration; Neutrophils; Pneumonia, Bacterial; Zinc	2012
Prolonged infusion of carbapenems in critically ill patients: time to extend our practice. Critical care medicine, 2013, Volume: 41, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Doripenem; Female; Humans; Male; Obesity; Pneumonia, Bacterial	2013
[Clinical efficacy of carbapenems in the treatment of destructive pneumonia and chronic purulent bronchitis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; Bronchitis, Chronic; Carbapenems; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Injections, Intramuscular; Injections, Intravenous; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Thienamycins	2003
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Tobramycin	2004
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:1 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Guinea Pigs; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Thienamycins; Treatment Outcome	2005
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Chest, 2006, Volume: 130, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical	2006
Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:1 Topics: Adult; Aged; Bacteremia; Carbapenems; Case-Control Studies; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Neoplasms; Neutropenia; Pneumonia, Bacterial; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Texas	2007
In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; Carbapenems; Dipeptidases; Drug Resistance, Multiple; Humans; Kidney; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrrolidines; Swine	1997
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Half-Life; Imipenem; Kidney Diseases; Male; Meropenem; Penicillinase; Pneumonia, Bacterial; Protein Binding; Rats; Rats, Wistar; Thienamycins; Uranyl Nitrate	2000
[Pneumonia associated with lung cancer in the elderly]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2002, Volume: 76, Issue:3 Topics: Aged; Carbapenems; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Penicillins; Pneumonia, Bacterial; Prognosis; Tetracycline	2002
Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:6 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance; Injections, Intraperitoneal; Lung; Male; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar	2002